down arrow

Biofil Chemicals

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
42.68
0.3 (0.71%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 8.46 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

42.2743.78

52 Week

40.5092.00
Valuation
Technical
Day's Volume

CASH

8.46 k (-89.36%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 1 FIIs

DII

0.08%

Held by 0 DIIs

Promoter

46.82%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -23.01% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.39
  • The company has been able to generate a Return on Equity (avg) of 4.52% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 3.3, it has a Expensive valuation with a 3.8 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 71 Cr (Micro Cap)

stock-summary
P/E

69.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

3.26%

stock-summary
Price to Book

3.75

Revenue and Profits (1 Year):
Net Sales:
14 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-43.07%
0%
-43.07%
1 Year
-36.41%
0%
-36.41%
2 Years
-4.3%
0%
-4.3%
3 Years
-34.99%
0%
-34.99%
4 Years
-41.53%
0%
-41.53%
5 Years
406.89%
0%
406.89%

Biofil Chemicals for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.19%
EBIT Growth (5y)
-23.01%
EBIT to Interest (avg)
0.39
Debt to EBITDA (avg)
0.47
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.88
Tax Ratio
21.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
5.66%
ROE (avg)
4.52%
Valuation key factors
Factor
Value
P/E Ratio
69
Industry P/E
33
Price to Book Value
3.75
EV to EBIT
69.21
EV to EBITDA
69.21
EV to Capital Employed
3.71
EV to Sales
1.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.07%
ROE (Latest)
3.26%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Scope Finance Company Private Limited (13.9%)

Highest Public shareholder

Starline Equifin Private Limited (7.51%)

Individual Investors Holdings

38.18%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 489.21% vs -71.45% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 700.00% vs -88.24% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.20",
          "val2": "2.41",
          "chgp": "489.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.31",
          "val2": "0.12",
          "chgp": "158.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.16",
          "val2": "0.02",
          "chgp": "700.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.18%",
          "val2": "4.98%",
          "chgp": "-2.80%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -45.15% vs 32.62% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -48.65% vs 48.00% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.86",
          "val2": "19.80",
          "chgp": "-45.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.44",
          "val2": "0.65",
          "chgp": "-32.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.02",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.19",
          "val2": "0.37",
          "chgp": "-48.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.05%",
          "val2": "3.28%",
          "chgp": "0.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.93% vs 51.22% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -23.91% vs 31.43% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.06",
          "val2": "24.83",
          "chgp": "0.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.75",
          "val2": "0.84",
          "chgp": "-10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.02",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.35",
          "val2": "0.46",
          "chgp": "-23.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.99%",
          "val2": "3.38%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 33.29% vs 34.23% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 26.79% vs -20.00% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.04",
          "val2": "30.04",
          "chgp": "33.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.82",
          "val2": "1.17",
          "chgp": "-29.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.04",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.71",
          "val2": "0.56",
          "chgp": "26.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.05%",
          "val2": "3.89%",
          "chgp": "-1.84%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
14.20
2.41
489.21%
Operating Profit (PBDIT) excl Other Income
0.31
0.12
158.33%
Interest
0.01
0.01
Exceptional Items
0.00
0.00
Standalone Net Profit
0.16
0.02
700.00%
Operating Profit Margin (Excl OI)
2.18%
4.98%
-2.80%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 489.21% vs -71.45% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 700.00% vs -88.24% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
10.86
19.80
-45.15%
Operating Profit (PBDIT) excl Other Income
0.44
0.65
-32.31%
Interest
0.02
0.02
Exceptional Items
0.00
0.00
Standalone Net Profit
0.19
0.37
-48.65%
Operating Profit Margin (Excl OI)
4.05%
3.28%
0.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -45.15% vs 32.62% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -48.65% vs 48.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
25.06
24.83
0.93%
Operating Profit (PBDIT) excl Other Income
0.75
0.84
-10.71%
Interest
0.03
0.02
50.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.35
0.46
-23.91%
Operating Profit Margin (Excl OI)
2.99%
3.38%
-0.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.93% vs 51.22% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -23.91% vs 31.43% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
40.04
30.04
33.29%
Operating Profit (PBDIT) excl Other Income
0.82
1.17
-29.91%
Interest
0.04
0.04
Exceptional Items
0.00
0.00
Standalone Net Profit
0.71
0.56
26.79%
Operating Profit Margin (Excl OI)
2.05%
3.89%
-1.84%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 33.29% vs 34.23% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 26.79% vs -20.00% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Biofil Chemicals & Pharmaceuticals Ltd stock-summary
stock-summary
Biofil Chemicals & Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.
Company Coordinates stock-summary
Company Details
11/12 Sector E Sanwer Road, Sanwer Road Industrial Area Indore Madhya Pradesh : 452015
stock-summary
Tel: 91-731-2426700
stock-summary
http://www.biofilgroup.net
stock-summary
bcplcompliance@gmail.com
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."